Mark R. Lilly
@Cm Management, Llc
Latest period2024 - Q3ReportedManaged Assets$125.3MTotal holdings64
Assets growth rate14.98%Assets growth rate (2-Q avg)3.26%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Cm Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 64 positions.
Assets under management
The assets under management (AUM) of Cm Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 125.3M in assets, with a quarterly growth rate of 14.98% and a 2-quarter average growth rate of 3.26%. The portfolio is managed by Mark R. Lilly, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
IOVAIovance Biotherapeutics Inc
| 1.88% | $2.348M 250,000 shares@ $9.39 avg price | |
VTRSViatris Inc
| 1.86% | $2.322M 200,000 shares@ $11.61 avg price | |
RBCAARepublic Bancorp
| 1.83% | $2.286M 35,000 shares@ $65.3 avg price | |
BRKLBrookline Bancorp Inc
| 1.82% | $2.27M 225,000 shares@ $10.09 avg price | Increased 18.43% |
JAZZJazz Pharmaceuticals Plc
| 1.78% | $2.228M 20,000 shares@ $111.41 avg price | Increased 60% |
CVSCvs Health Corp
| 1.76% | $2.201M 35,000 shares@ $62.88 avg price | Increased 16.67% |
PKPark Hotels Resorts Inc
| 1.69% | $2.115M 150,000 shares@ $14.1 avg price | Increased 200% |
CHRSCoherus Biosciences Inc
| 1.67% | $2.08M 2M shares@ $1.04 avg price | Increased 81.82% |
OGNOrganon & Co
| 1.53% | $1.913M 100,000 shares@ $19.13 avg price | Decreased -20% |
THFFFirst Finl Corp
| 1.49% | $1.864M 42,500 shares@ $43.85 avg price | Increased 6.25% |